Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 187.70
+6.20 (3.42%)
Aug 20, 2026, 4:09 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 16.42 billion as of August 20, 2026. Its market cap has decreased by -46.23% in one year.
Market Cap
16.42B
Enterprise Value
12.82B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
187.70
ChartMarket Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has decreased from 17.51B to 16.42B, a decrease of -6.27%. That is a compound annual growth rate of -4.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 16.42B | -38.43% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 22.99B |
| Zai Lab | 22.58B |
| Nanjing Leads Biolabs | 14.90B |
| Metis TechBio | 14.76B |
| Ascentage Pharma Group International | 12.95B |
| HBM Holdings | 12.83B |
| GenFleet Therapeutics (Shanghai) | 11.56B |
| Ascletis Pharma | 11.04B |